MDCalc

Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis

Predicts need for VTE prophylaxis in admitted patients.

Note: This score is distinct from the Geneva Score (Revised) for PE, which assesses the diagnostic probability of PE in patients presenting with relevant signs and symptoms.

Cardiac failure
Respiratory failure
Recent stroke
<3 months ago
Recent myocardial infarction
<4 weeks ago
Acute infectious disease
Including sepsis
Acute rheumatic disease
Active malignancy
Myeloproliferative syndrome
Nephrotic syndrome
Any prior VTE

Known hypercoagulable state

Immobilization for ≥3 days

<30 min of walking per day
Recent travel for >6 hrs
Age >60 years

BMI >30 kg/m²

Chronic venous insufficiency

Pregnancy

Hormonal therapy

Contraceptive or replacement therapy

Dehydration

Result:

Please fill out required fields.
Advice
  • Use the score to complement, not replace, clinical judgment when making therapeutic decisions.
  • Risk factors for VTE (especially mobility status) can evolve during hospitalization; reassess periodically.
Management
  • Low risk (score <3): 
    • Routine pharmacologic thromboprophylaxis is generally not indicated.
    • Prioritize early mobilization and reassess if status changes.
  • High risk (score ≥3): 
    • Initiate pharmacologic prophylaxis per local protocol (e.g., LMWH/UFH) after bleeding-risk assessment.
    • Emphasize early mobilization and use mechanical methods when pharmacologic agents are contraindicated or insufficient.
Critical Actions

Always weigh bleeding risk before prescribing anticoagulant prophylaxis; consider a formal tool, such as the IMPROVE Bleeding Risk Score.

Have feedback about this calculator?